Logo image of KRO

KRONOS WORLDWIDE INC (KRO) Stock Fundamental Analysis

USA - NYSE:KRO - US50105F1057 - Common Stock

4.92 USD
+0.12 (+2.5%)
Last: 10/31/2025, 8:04:00 PM
4.92 USD
0 (0%)
After Hours: 10/31/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, KRO scores 4 out of 10 in our fundamental rating. KRO was compared to 82 industry peers in the Chemicals industry. There are concerns on the financial health of KRO while its profitability can be described as average. KRO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year KRO was profitable.
In the past year KRO has reported a negative cash flow from operations.
Of the past 5 years KRO 4 years were profitable.
Each year in the past 5 years KRO had a positive operating cash flow.
KRO Yearly Net Income VS EBIT VS OCF VS FCFKRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.48%, KRO is in the better half of the industry, outperforming 69.51% of the companies in the same industry.
KRO has a Return On Equity of 7.97%. This is in the better half of the industry: KRO outperforms 71.95% of its industry peers.
KRO's Return On Invested Capital of 5.53% is fine compared to the rest of the industry. KRO outperforms 62.20% of its industry peers.
Industry RankSector Rank
ROA 3.48%
ROE 7.97%
ROIC 5.53%
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
KRO Yearly ROA, ROE, ROICKRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

Looking at the Profit Margin, with a value of 3.57%, KRO is in the better half of the industry, outperforming 63.41% of the companies in the same industry.
In the last couple of years the Profit Margin of KRO has declined.
KRO has a Operating Margin of 5.74%. This is in the lower half of the industry: KRO underperforms 60.98% of its industry peers.
KRO's Operating Margin has declined in the last couple of years.
KRO's Gross Margin of 18.88% is on the low side compared to the rest of the industry. KRO is outperformed by 67.07% of its industry peers.
In the last couple of years the Gross Margin of KRO has declined.
Industry RankSector Rank
OM 5.74%
PM (TTM) 3.57%
GM 18.88%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
KRO Yearly Profit, Operating, Gross MarginsKRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KRO is destroying value.
Compared to 1 year ago, KRO has about the same amount of shares outstanding.
The number of shares outstanding for KRO has been reduced compared to 5 years ago.
KRO has a worse debt/assets ratio than last year.
KRO Yearly Shares OutstandingKRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
KRO Yearly Total Debt VS Total AssetsKRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that KRO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.74, KRO perfoms like the industry average, outperforming 42.68% of the companies in the same industry.
KRO has a Debt/Equity ratio of 0.59. This is a neutral value indicating KRO is somewhat dependend on debt financing.
KRO has a Debt to Equity ratio of 0.59. This is in the better half of the industry: KRO outperforms 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC0.6
WACC9.15%
KRO Yearly LT Debt VS Equity VS FCFKRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.79 indicates that KRO has no problem at all paying its short term obligations.
KRO has a Current ratio of 2.79. This is in the better half of the industry: KRO outperforms 76.83% of its industry peers.
KRO has a Quick Ratio of 1.04. This is a normal value and indicates that KRO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.04, KRO is doing worse than 65.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 1.04
KRO Yearly Current Assets VS Current LiabilitesKRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

KRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
The earnings per share for KRO have been decreasing by -24.83% on average. This is quite bad
KRO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.51%.
Measured over the past years, KRO shows a small growth in Revenue. The Revenue has been growing by 1.74% on average per year.
EPS 1Y (TTM)100%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-147.06%
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-1.22%

3.2 Future

The Earnings Per Share is expected to grow by 75.60% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 1.50% on average over the next years.
EPS Next Y-116.83%
EPS Next 2Y70.82%
EPS Next 3Y75.6%
EPS Next 5YN/A
Revenue Next Year-10.45%
Revenue Next 2Y-2.44%
Revenue Next 3Y1.5%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
KRO Yearly Revenue VS EstimatesKRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
KRO Yearly EPS VS EstimatesKRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 246.00 indicates a quite expensive valuation of KRO.
Compared to the rest of the industry, the Price/Earnings ratio of KRO indicates a slightly more expensive valuation: KRO is more expensive than 69.51% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of KRO to the average of the S&P500 Index (26.10), we can say KRO is valued expensively.
With a Price/Forward Earnings ratio of 9.37, the valuation of KRO can be described as very reasonable.
KRO's Price/Forward Earnings ratio is rather cheap when compared to the industry. KRO is cheaper than 84.15% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of KRO to the average of the S&P500 Index (22.52), we can say KRO is valued rather cheaply.
Industry RankSector Rank
PE 246
Fwd PE 9.37
KRO Price Earnings VS Forward Price EarningsKRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

KRO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. KRO is cheaper than 81.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.74
KRO Per share dataKRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

KRO's earnings are expected to grow with 75.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.82%
EPS Next 3Y75.6%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.14%, KRO is a good candidate for dividend investing.
KRO's Dividend Yield is rather good when compared to the industry average which is at 3.79. KRO pays more dividend than 82.93% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, KRO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.14%

5.2 History

The dividend of KRO decreases each year by -7.80%.
KRO has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-7.8%
Div Incr Years0
Div Non Decr Years0
KRO Yearly Dividends per shareKRO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

KRO pays out 34.07% of its income as dividend. This is a sustainable payout ratio.
DP34.07%
EPS Next 2Y70.82%
EPS Next 3Y75.6%
KRO Yearly Income VS Free CF VS DividendKRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
KRO Dividend Payout.KRO Dividend Payout, showing the Payout Ratio.KRO Dividend Payout.PayoutRetained Earnings

KRONOS WORLDWIDE INC

NYSE:KRO (10/31/2025, 8:04:00 PM)

After market: 4.92 0 (0%)

4.92

+0.12 (+2.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners17.24%
Inst Owner Change-2.45%
Ins Owners0.17%
Ins Owner Change0.13%
Market Cap566.05M
Revenue(TTM)1.89B
Net Income(TTM)67.50M
Analysts46.67
Price Target8.16 (65.85%)
Short Float %8.12%
Short Ratio5.24
Dividend
Industry RankSector Rank
Dividend Yield 4.14%
Yearly Dividend0.48
Dividend Growth(5Y)-7.8%
DP34.07%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-05 2025-09-05 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-82.74%
Min EPS beat(2)-158.67%
Max EPS beat(2)-6.81%
EPS beat(4)0
Avg EPS beat(4)-107.62%
Min EPS beat(4)-188.88%
Max EPS beat(4)-6.81%
EPS beat(8)3
Avg EPS beat(8)28.83%
EPS beat(12)4
Avg EPS beat(12)-22.07%
EPS beat(16)7
Avg EPS beat(16)-10.9%
Revenue beat(2)0
Avg Revenue beat(2)-3.15%
Min Revenue beat(2)-3.28%
Max Revenue beat(2)-3.02%
Revenue beat(4)0
Avg Revenue beat(4)-9.32%
Min Revenue beat(4)-15.74%
Max Revenue beat(4)-3.02%
Revenue beat(8)2
Avg Revenue beat(8)-4.84%
Revenue beat(12)4
Avg Revenue beat(12)-3.11%
Revenue beat(16)7
Avg Revenue beat(16)-1.55%
PT rev (1m)0%
PT rev (3m)-8.57%
EPS NQ rev (1m)-180%
EPS NQ rev (3m)-134.29%
EPS NY rev (1m)-109.68%
EPS NY rev (3m)-103.8%
Revenue NQ rev (1m)-9.04%
Revenue NQ rev (3m)-9.51%
Revenue NY rev (1m)-5.15%
Revenue NY rev (3m)-8.26%
Valuation
Industry RankSector Rank
PE 246
Fwd PE 9.37
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB 0.67
EV/EBITDA 6.74
EPS(TTM)0.02
EY0.41%
EPS(NY)0.53
Fwd EY10.67%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS16.45
BVpS7.36
TBVpS7.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.82
Profitability
Industry RankSector Rank
ROA 3.48%
ROE 7.97%
ROCE 7.01%
ROIC 5.53%
ROICexc 5.6%
ROICexgc 5.61%
OM 5.74%
PM (TTM) 3.57%
GM 18.88%
FCFM N/A
ROA(3y)2.41%
ROA(5y)3.2%
ROE(3y)5.13%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-13.41%
ROICexgc growth 5Y-3.71%
ROICexc growth 3Y-13.47%
ROICexc growth 5Y-3.75%
OM growth 3Y-12.41%
OM growth 5Y-5.03%
PM growth 3Y-7.77%
PM growth 5Y-1.91%
GM growth 3Y-6.11%
GM growth 5Y-3.12%
F-Score3
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 3.01
Cap/Depr 76.9%
Cap/Sales 2.36%
Interest Coverage 2.04
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.79
Quick Ratio 1.04
Altman-Z 1.74
F-Score3
WACC9.15%
ROIC/WACC0.6
Cap/Depr(3y)89.54%
Cap/Depr(5y)98.19%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3Y-43.16%
EPS 5Y-24.83%
EPS Q2Q%-147.06%
EPS Next Y-116.83%
EPS Next 2Y70.82%
EPS Next 3Y75.6%
EPS Next 5YN/A
Revenue 1Y (TTM)6.51%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.74%
Sales Q2Q%-1.22%
Revenue Next Year-10.45%
Revenue Next 2Y-2.44%
Revenue Next 3Y1.5%
Revenue Next 5YN/A
EBIT growth 1Y271.92%
EBIT growth 3Y-13.2%
EBIT growth 5Y-3.37%
EBIT Next Year16.79%
EBIT Next 3Y26.65%
EBIT Next 5YN/A
FCF growth 1Y56.05%
FCF growth 3Y-33.75%
FCF growth 5Y-16.38%
OCF growth 1Y90.72%
OCF growth 3Y-29.45%
OCF growth 5Y-14.67%

KRONOS WORLDWIDE INC / KRO FAQ

What is the ChartMill fundamental rating of KRONOS WORLDWIDE INC (KRO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to KRO.


What is the valuation status for KRO stock?

ChartMill assigns a valuation rating of 4 / 10 to KRONOS WORLDWIDE INC (KRO). This can be considered as Fairly Valued.


Can you provide the profitability details for KRONOS WORLDWIDE INC?

KRONOS WORLDWIDE INC (KRO) has a profitability rating of 4 / 10.


How financially healthy is KRONOS WORLDWIDE INC?

The financial health rating of KRONOS WORLDWIDE INC (KRO) is 3 / 10.


What is the expected EPS growth for KRONOS WORLDWIDE INC (KRO) stock?

The Earnings per Share (EPS) of KRONOS WORLDWIDE INC (KRO) is expected to decline by -116.83% in the next year.